Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 13;11(12):2454.
doi: 10.3390/antiox11122454.

The Role of Heme Oxygenase-1 as an Immunomodulator in Kidney Disease

Affiliations
Review

The Role of Heme Oxygenase-1 as an Immunomodulator in Kidney Disease

Virginia Athanassiadou et al. Antioxidants (Basel). .

Abstract

The protein heme oxygenase (HO)-1 has been implicated in the regulations of multiple immunological processes. It is well known that kidney injury is affected by immune mechanisms and that various kidney-disease forms may be a result of autoimmune disease. The current study describes in detail the role of HO-1 in kidney disease and provides the most recent observations of the effect of HO-1 on immune pathways and responses both in animal models of immune-mediated disease forms and in patient studies.

Keywords: heme oxygenase; immune injury; kidney.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of the glomerulus. The glomerulus is a cluster of capillaries within the Bowman’s capsule. Three different cell types comprise the glomerulus: endothelial cells, epithelial cells (podocytes) and mesangial cells. Endothelial cells are fenestrated, while mesangial cells and the mesangial matrix support the glomerular capillaries. Podocytes are located on the urinary side of the glomerular basement membrane, and they have long foot processes that wrap around the glomerular capillaries.
Figure 2
Figure 2
HO-1 immunomodulatory effects in glomerular diseases. Schematic representation of the effect of HO-1 in diseases that affect the glomerulus.

Similar articles

Cited by

References

    1. Barratt J., Feehally J. IgA nephropathy. J. Am. Soc. Nephrol. JASN. 2005;16:2088–2097. doi: 10.1681/ASN.2005020134. - DOI - PubMed
    1. Saha M.K., Julian B.A., Novak J., Rizk D.V. Secondary IgA nephropathy. Kidney Int. 2018;94:674–681. doi: 10.1016/j.kint.2018.02.030. - DOI - PMC - PubMed
    1. Penfold R.S., Prendecki M., McAdoo S., Tam F.W. Primary IgA nephropathy: Current challenges and future prospects. Int. J. Nephrol. Renov. Dis. 2018;11:137–148. doi: 10.2147/IJNRD.S129227. - DOI - PMC - PubMed
    1. Suzuki H. Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis. Clin. Exp. Nephrol. 2019;23:26–31. doi: 10.1007/s10157-018-1582-2. - DOI - PMC - PubMed
    1. Dotz V., Visconti A., Lomax-Browne H.J., Clerc F., Hipgrave Ederveen A.L., Medjeral-Thomas N.R., Cook H.T., Pickering M.C., Wuhrer M., Falchi M. O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function. J. Am. Soc. Nephrol. JASN. 2021;32:2455–2465. doi: 10.1681/ASN.2020081208. - DOI - PMC - PubMed

LinkOut - more resources